RECONCILIATION OF NET PROFIT TO UNITHOLDERS DISTRIBUTION
Notes
FY15
S$'000
FY14
S$'000
Net profit for the period attributable to unitholders of the Trust
37,423
41,473
Distribution adjustments:
Impact of non-cash straight-lining
(5,451)
(12,250)
Technology renewal fee
(694)
(624)
Depreciation and amortisation
13,908
12,691
Amortisation of debt arrangement fee
607
616
Trustee-Manager fees payable in units
3,619
2,612
Deferred tax
6,842
2,028
Foreign exchange differences
I
(2,392)
865
Capital expenditure
II
(944)
(717)
Transaction cost capital in nature
III
5,494
–
Unrealised gain on financial asset
(246)
–
Total distributable income attributable to unitholders of the Trust
58,166
46,694
Notes:
I
Included in foreign exchange differences are
(i) adjustments for the distributable income based on the average forward contracted INR/SGD rate against INR/SGD for the translation of the statement of
comprehensive income; (ii) changes in fair value on financial derivatives and; (iii) foreign exchange differences recorded in the statement of comprehensive income.
II This relates to operating cash flow being used to partially fund capital expenditure.
III The FY15 YTD amount relates to the one off stamp duty and professional fees in connection to the acquisition of the Mohali Clinical Establishment which
are treated as capital in nature offset by the non-cash gain recognised in connection with the Mohali acquisition. The amount incurred in the current quarter
relates to adjustment to the non-cash gain that was recognised as mentioned above, post the completion of the purchase price allocation.
Performance
Highlights
RHT UNIT PRICE AND TRADING VOLUME
0.85
0.80
0.90
0.95
1.00
1.05
1.10
1.15
4.00
0.00
8.00
12.0
16.0
20.0
24.0
28.0
1 April 2014 To 31 March 2015
RHT UNIT PRICE
(S$)
VOLUMETRADED
(MILLIONS OF UNITS)
Volume Traded
RHT Unit Closing Price
Source: Bloomberg
S$
0.845
UNIT CLOSING PRICE
ON 1 APRIL 2014
S$
1.09
UNIT CLOSING PRICE
ON 31 MARCH 2015
S$
1.105
HIGHEST CLOSING PRICE
(5 FEBRUARY 2015)
S$
0.845
LOWEST CLOSING PRICE
(1 APRIL 2014)
RELIGARE HEALTH TRUST
6
